An English-qualified solicitor, Mark Darley has led Skadden’s European law banking practice since joining the firm in April 2002 and was appointed global co-head of Skadden’s Banking Group in 2009.


Throughout his career, Mr. Darley has focused particularly on leveraged finance, restructuring and project finance transactions. His practice embraces advising both lenders and borrowers, including international financial institutions, private equity houses, hedge and other funds, and investment grade corporates. Clients have included BAML, Citibank, Credit Suisse, Deutsche Bank, J.P. Morgan, RBS, SG, SEB, UCB SA, Joh. A. Benckiser, AbbVie, Apax, M7 Real Estate, Formation Capital, Ares Life Sciences, Jacobs Douwe Egberts, Pfizer Inc., News Corporation, Vue Cinemas, China Investment Corporation, Vitol, ATAS, Vivo Energy, ContourGlobal, J.C. Flowers, Doughty Hanson and Oaktree.

Notable transactions include advising:

  • WABCO Holdings Inc. in its US$7 billion acquisition by ZF Friedrichshafen AG;
  • Waypoint GP Limited, an investment fund created by the Bertarelli family, in its €730 million take-private acquisition of Stallergenes Greer plc; 
  • Joh. A. Benckiser GmbH in connection with:
    • the expedited financing of its US$9.8 billion acquisition of D.E Master Blenders 1753 N.V; and
    • the subsequent financing of the combination of the coffee businesses of D.E. Master Blenders and Mondelez International, Inc., including advising in its reported €7.6 billion leveraged financing. This was Europe’s largest post-credit crisis leveraged loan transaction and was awarded “Loan Deal of the Year” at the 2015 IFLR European Awards;
  • Jacobs Douwe Egberts in its €5.8 billion secured, cross-border refinancing and in its US$1.1 billion acquisition of Super Group Ltd;
  • AbbVie Inc. in the financing for its proposed US$54 billion acquisition of Shire plc, including a £13.5 billion bridge loan facility;
  • Pfizer Inc. in the financing for its proposed US$115 billion acquisition of AstraZeneca Plc through a newly formed U.K. holding company;
  • Seat Pagine Gialle S.p.A. in its filing for a composition with creditors for the restructuring of its senior secured bonds and debt facilities;
  • Vue Cinemas Limited in its bid for CinemaxX AG, a German public company;
  • Credit Suisse in the provision of acquisition financing to TPG Capital LLP for its bid for GlobeOp Financial Services SA (Luxembourg), a hedge fund administrator;
  • Alfa-Access-Renova (AAR) in the financing aspects of the US$56 billion sale of TNK-BP, a joint venture between AAR and BP plc, to Rosneft Oil Company;
  • Outokumpu in connection with:
    • the refinancing of various syndicate and bilateral facilities; and
    • its acquisition of ThyssenKrupp’s stainless steel business;
  • J.C. Flowers in its acquisition of Compagnie Européenne de Prévoyance in France;
  • UCB SA in a €1.5 billion financing;
  • various private equity houses in connection with the acquisition of portfolio companies, including Apax, Apollo, Doughty Hanson, JW Childs, Oaktree, Towerbrook and TPG;
  • Basell Polyolefins in its US$23 billion financing for its acquisition of Lyondell Chemical Company and in its proposed US$9.6 billion acquisition of Huntsman Corporation;
  • TerraForm Power LLC subsidiaries in the reorganisation of 23 separate project companies into a consolidated group, the simultaneous refinancing 13 of their financings and a dividend recap through a new £314 million leveraged facility;
  • J.P. Morgan in the financing of Deutsche Annington Immobilien SE’s €3.9 billion public takeover bid for all of the outstanding shares in GAGFAH S.A.;
  • Affidea B.V. in its cross border, secured €500 million credit facility to finance its existing indebtedness and provide for acquisition and capex facilities;
  • Aspen Technology, Inc. and its subsidiary ATI Global Optimisation Ltd in the financing of its US$230 million acquisition of KBC Advanced Technologies plc;
  • Coty Inc. in connection with the financing of its £420 million acquisition of ghd (Good Hair Day) from Lion Capital LLP;
  • Doughty Hanson & Co in connection with its acquisition of Zobele;
  • NASDAQ in the financing of its bid for the London Stock Exchange;
  • Citibank, RBS, SG and SEB in their financing of a bid for a publicly listed company;
  • UCB SA in the financing for its bid for Schwarz Pharma;
  • News Corporation in the financing aspects of the US$3.6 billion going-private acquisition of NDS Group plc;
  • The Vitol Group and Helios Investment Partners LLP in the financing of the acquisition of Royal Dutch Shell plc’s downstream assets in 14 African jurisdictions;
  • TeleColumbus GmbH in the restructuring of its debt financing;
  • Access Industries in the Chapter 11 proceedings and DIP financing for LBI;
  • various financings for infrastructure and mining projects; and
  • several private equity portfolio companies in the restructuring of their leveraged finance facilities.

Mr. Darley has been selected repeatedly for inclusion in Chambers Global: The World’s Leading Lawyers for Business, Chambers UK and Who’s Who Legal – Banking, in addition to The Legal 500 in its U.K. Hall of Fame 2018 and as “Leveraged Finance Lawyer of the Year in England 2014” by Global Law Experts.



  • LL.B. (Honours), Manchester University, 1983
  • College of Law, Chester (Law Society Final Examinations), 1984


  • Solicitor, England & Wales

Mark L. Darley